Navigation Links
Doctors worried about Homeopathic licensing

The government today introduced a controversial licensing scheme. According to it, the packaging or covering on the homeopathic products// will be permitted to describe the ailments they claim to be able to cure.

With the aim to bring homeopathic remedies into the area of licensed medicines, the National Rules System was designed. However, doctors and scientists believe that products with no scientific proof to confirm their claims will be legitimized by it.

Kent Woods, chief executive of the Medicines and Healthcare Products Regulatory Agency (MHRA), the government agency responsible for licensing medicines and ensuring their safety, said: "This is a significant step forward in the way homeopathic medicines are regulated. Products authorised will have to comply with recognised standards of quality, safety and patient information."

The rules "diluted and polluted" regulation of medicines, said the Liberal Democrat MP Evan Harris on the Commons science committee. "The multi-million pound homeopathy industry should not be allowed to make health claims for its products without proper evidence of effectiveness," he said.

Medicines have required scientific data to prove their efficacy to get a license ever since 1971.

Homeopathic products were not allowed to be categorized as medicine or permitted to put any claims on packaging about ailments they profess to cure, because they lacked proof of their efficacy. These products will get license from the MRHA based on "homeopathic provings", observations of the symptoms (such as watering eyes or headaches) a person gets when given a particular substance.

Michael Baum, emeritus professor of surgery at University College London said: "This is like licensing a witches' brew as a medicine so long as the bat wings are sterile."

However, Penny Viner of the British Association of Homeopathic Manufacturers feels that this scheme would promote growth in the range of products on the market and would improve customers’ knowledge about their advantages.
GAY
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, Patten ... , The seed processing plant opened in Marshallville in 2006, and a bagging and ... allows opportunity for transition of Patten Seed operations to the Middle Georgia location from ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... replace their missing teeth can now have them placed by Dr. Manju Kejriwal, with ... i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. The ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: